John Richard Riordan (Also known as Jack) (born September 2, 1943 in St. Stephen, New Brunswick) is a Canadian biochemist, [1] noted for his research into Cystic Fibrosis.
After acquiring his bachelor's degree in 1966 from the University of Toronto, he studied and received a doctorate in biochemistry from the same university in 1970. His next three years were spent at the Max Planck Institute for Biophysics in Frankfurt. He then returned to the University of Toronto, where he worked as a professor in the Biochemistry department from 1974. Prior to retiring in 2018, Riordan was a professor at the University of North Carolina at Chapel Hill where he was a member of the Biochemistry and Biophysics Department studying the structure and function of CFTR. He is also a visiting scientist at the Academy Salhgrenska (where he holds an honorary doctorate ) and University of Gothenburg.
He is mostly recognized for the first ever discovery of a mutated gene, ΔF508, that can cause cystic fibrosis. This research was undertaken alongside fellow biologists, Francis Collins and Lap-Chee Tsui and since then, other research has found over 1000 different mutations that can cause cystic fibrosis.
In 1990 he received the Gairdner Foundation International Award, 'for contributions to the identification of the gene for cystic fibrosis'. [2]
Cystic fibrosis (CF) is a genetic disorder that affects mostly the lungs, but also the pancreas, liver, kidneys, and intestine. Long-term issues include difficulty breathing and coughing up mucus as a result of frequent lung infections. Other signs and symptoms may include sinus infections, poor growth, fatty stool, clubbing of the fingers and toes, and infertility in most males. Different people may have different degrees of symptoms.
Lap-Chee Tsui is a Chinese-born Canadian geneticist and served as the 14th Vice-Chancellor and President of the University of Hong Kong.
Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and chloride channel in vertebrates that is encoded by the CFTR gene.
The Cystic Fibrosis Trust, is a UK-based national charity founded in 1964, dealing with all aspects of cystic fibrosis (CF). It funds research to treat and cure CF and aims to ensure appropriate clinical care and support for people with cystic fibrosis.
Dorothy Hansine Andersen was an American physician, pediatrician, and pathologist who was the first person to identify cystic fibrosis, the first to describe the disease, and the one to name it. in 1939, she was awarded the E. Mead Johnson Award for her identification of the disease. In 2002, she was inducted into the National Women's Hall of Fame.
Pancreatic diseases are diseases that affect the pancreas, an organ in the human body located in the abdomen. The pancreas plays a role in the digestive and endocrine system, producing enzymes which aid the digestion process and the hormone insulin, which regulates blood sugar levels. The most common pancreatic disease is pancreatitis, an inflammation of the pancreas which could come in acute or chronic form. Other pancreatic diseases include Diabetes mellitus, Exocrine pancreatic insufficiency, Cystic fibrosis, Pseudocysts, Cysts, Congenital malformations, Neoplasms and Hemosuccus pancreaticus.
Manuel Buchwald, is a Canadian geneticist and academic.
Jeremy Mark Berg was founding director of the University of Pittsburgh Institute for Personalized Medicine. He holds positions as Associate Senior Vice Chancellor for Science Strategy and Planning and Professor of Computational and Systems Biology at the University of Pittsburgh. From 2016 - 2019, Berg was editor in chief of the Science journals.
Gregory A. Petsko is an American biochemist and member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society. He is currently Professor of Neurology at the Ann Romney Center for Neurologic Diseases at Harvard Medical School and Brigham and Women's Hospital. He formerly had an endowed professorship in Neurology and Neuroscience at Weill Cornell Medical College and is still an adjunct professor of Biomedical Engineering at Cornell University, and is also the Gyula and Katica Tauber Professor, Emeritus, in biochemistry and chemistry at Brandeis University.
The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality and impact on our understanding of biological systems and processes. The award may recognize a specific contribution or series of contributions that demonstrate the nominee’s significant leadership in the development of research concepts or their clinical application. Particular emphasis will be placed on research that champions novel approaches and challenges accepted thinking in the biomedical sciences.
Wayne A. Hendrickson is an American biophysicist and University professor at Columbia. Dr. Hendrickson is a University Professor at Columbia University in the Department of Biochemistry and Molecular Biophysics and Violin Family Professor of Physiology and Cellular Biophysics. He is also Chief Life Scientist in the Photon Sciences Directorate at Brookhaven National Laboratory and Scientific Director of the New York Structural Biology Center. Hendrickson has a B.A. from the University of Wisconsin at River Falls, a Ph.D. in biophysics at Johns Hopkins University with Warner Love, and postdoctoral research experience with Jerome Karle at the Naval Research Laboratory (NRL). He and his colleagues use biochemistry and x-ray crystallography to study molecular properties in atomic detail with current emphasis on membrane receptors and cellular signaling, on viral proteins and HIV infection, on molecular chaperones and protein folding, and on structural genomics of membrane proteins. Hendrickson's advances in diffraction methodology have contributed significantly to the emergence of structural biology as a major force in modern biology and molecular medicine.
Ronald G. Worton is a Canadian doctor.
David Shugar was a professor of the University of Warsaw.
Dr. John Engelhardt is the director at the University of Iowa Center for Gene Therapy of Cystic Fibrosis, as well as the head of the department of anatomy and cell biology. He is a well known scientist and inventor who created the first cloned ferret and has made huge strides in finding the cure for cystic fibrosis.
Robert Williamson is a retired British-Australian molecular biologist who specialised in the mapping, gene identification, and diagnosis of human genetic disorders.
Barbara Hyde Bowman was an American biologist, geneticist, and educator who was known for her research in human blood proteins. Her work characterized variants of globins, the family of proteins responsible for transporting blood in oxygen, and in 1984, Oliver Smithies and she showed that variations in haptoglobins were due to polymorphisms in the HP gene.
Józef Dulak is a Polish scientist and professor of biological sciences from Rytro.
Johanna Rommens is a Canadian geneticist who was on the research team which identified and cloned the CFTR gene, which when mutated, is responsible for causing cystic fibrosis (CF). She later discovered the gene responsible for Shwachman-Diamond syndrome, a rare genetic disorder that causes pancreatic and hematologic problems. She is a Senior Scientist Emeritus at SickKids Research Institute and a Professor in the Department of Molecular Genetics at the University of Toronto.
Batsheva Kerem is an Israeli geneticist who was on the research team that identified and cloned the CFTR gene, which when mutated, is responsible for causing cystic fibrosis (CF). She later established the Israel National Center for CF Genetic Research. She discovered the most prevalent cystic fibrosis-causing mutations among the Israeli population, allowing for the establishment of nationwide genetic screening programs to identify carriers of these mutations and enabling prenatal diagnoses. She researches how some CF mutations prevent CFTR protein production by causing nonsense-mediated decay and abnormal mRNA splicing, and how therapies might be able to counteract those problems. She also studies the role of genetic instability in cancer. She is currently a professor at the Hebrew University.
Nikolay V. Dokholyan is a Russian-American biophysicist, academic and researcher. He is a G. Thomas Passananti Professor and Vice Chair for Research at Penn State College of Medicine.